Keyphrases
Paclitaxel
100%
Human Breast Cancer Cells
100%
Cyclin-dependent Kinase 1 (CDK1)
100%
CDK2 Activity
100%
Paclitaxel Sensitivity
100%
Tumor
40%
Specific Activity
33%
Cyclin-dependent Kinase 2 (CDK2)
20%
Kinase Activity
13%
Xenograft Tumor
13%
Spindle Assembly Checkpoint
13%
Assay System
6%
Protein Expression
6%
Clinical Setting
6%
Cancer Cells
6%
In Cancer
6%
Protein Kinase
6%
Morphological Analysis
6%
Chromatin
6%
Xenograft Model
6%
Drug Sensitivity
6%
Induced Cell Death
6%
Well-defined
6%
Expression Activity
6%
Human Breast Cancer
6%
Cyclin
6%
Cyclin-dependent Kinase
6%
Breast Cancer Treatment
6%
Growth State
6%
Biological Response
6%
Cell Viability Assay
6%
Breast Cancer Xenograft
6%
Activation State
6%
Drug-resistant Tumor
6%
Human Breast Cancer Cell Lines
6%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Paclitaxel
100%
Neoplasm
52%
Malignant Neoplasm
5%
Phosphotransferase
5%
Cycline
5%
Cell Viability
5%
Cyclin Dependent Kinase
5%
Viability Assay
5%
Cyclin Dependent Kinase 1
5%
Neuroscience
M Phase Cell Cycle Checkpoint
11%